Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Wire Hong Kong.
Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025
GlobeNewswire, Inc.
·
September 12, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 12, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will host a Research & Development update in Shanghai, China, and via webcast...
Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India
GlobeNewswire, Inc.
·
August 29, 2025
Pratteln, Switzerland, 29 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE® (vamorolone) in India, for the treatment of...
UM holds opening ceremony for Doctor of Public Health programme
Macao Government News
·
August 29, 2025
MACAU, August 29 - The Faculty of Health Sciences (FHS) at the University of Macau (UM) held an opening ceremony for the 2025/2026 intake of its Doctor of Public Health (DrPH) programme. The programme has admitted 35 new students this year,...
Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting
GlobeNewswire, Inc.
·
September 12, 2025
HONG KONG, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the “Company”) announced that during the Extraordinary General Meeting of Shareholders (the “Meeting”) held today at 11:00 a.m. at the Company’s office...
U.S. Concierge Medicine Market Size to Exceed USD 11.97 Billion by 2034 Driven by Rising Demand for Personalized and Preventive Healthcare
GlobeNewswire, Inc.
·
August 28, 2025
Ottawa, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The U.S. concierge medicine market size accounted for USD 6.55 billion in 2025 and is estimated to grow from USD 6.99 billion in 2026 to approximately USD 11.01 billion by 2033. Growing demand for...
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025
GlobeNewswire, Inc.
·
August 25, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
GlobeNewswire, Inc.
·
August 21, 2025
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
GlobeNewswire, Inc.
·
August 20, 2025
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverage Commenced commercial sales of Lisaftoclax in China, following...
Environmental Crimes Bulletin - August 2025
The U.S. Attorney's Office District of Puerto Rico
·
September 12, 2025
View All Environmental Crimes Bulletins In This Issue: Cases by District/Circuit Trials United States v. Leshon E. Johnson No. 6:25-CR-00012 (Easten District of Oklahoma) ECS Senior Litigation Counsel Todd Gleason ECS Trial Attorney Sarah Brown...
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
GlobeNewswire, Inc.
·
August 17, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel,...
Triumph Haofeng Agriculture Group Co., Ltd.’s high-end fruit tomato brand YIKEDA debuts at Asia Fruit Logistica
GlobeNewswire, Inc.
·
September 11, 2025
HONG KONG, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Recently, the high-end fruit tomato brand YIKEDA made its appearance at the 18th Asia Fruit Logistica, which attracted numerous merchants and continuous collaboration, showcasing the brand's strong...
New Report Identifies Drivers and Motivations Behind Ultra-High-Net-Worth Family Giving in Asia
EIN Presswire
·
September 9, 2025
Centre for Asian Philanthropy and Society (CAPS) Releases Report Examining the Drivers and Motivations Behind Why Ultra-High-Net-Worth Families Give in Asia HONG KONG, September 9, 2025 /EINPresswire.com/ -- The Centre for Asian Philanthropy and...
MPU Hosts the “15th National Games” Macao-wide English Speech Contest with Registration Now Open
Macao Government News
·
September 10, 2025
MACAU, September 10 - Seizing the opportunity of this year’s joint hosting of the National Games by Guangdong, Hong Kong, and Macao, the Macao Polytechnic University (MPU) is organizing the 24th Macao-wide English Speech Contest, themed the “15th...
Huize Holding Limited Reports Second Quarter 2025 Unaudited Financial Results
GlobeNewswire, Inc.
·
September 12, 2025
SHENZHEN, China, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers, and distribution partners digitally...
CoinEx Strengthens CET Value with Accumulated $142M Burn, Reinforcing Long-Term Commitment
GlobeNewswire, Inc.
·
September 9, 2025
HONG KONG, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CoinEx, a leading global cryptocurrency exchange, has announced the successful completion of its 8th Monthly CET Repurchase and Burning of 2025, eliminating a total of 22,207,653.46 CET from...
Cracks Beneath the Surface: New Consensus Sheds Light on Cemental Tear
EIN Presswire
·
September 10, 2025
Researchers created a standardized approach to identify cemental tears, reducing misdiagnosis and improving patient outcomes CHINA, September 10, 2025 /EINPresswire.com/ -- Cemental tear is a rare dental condition where the cementum detaches...
InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore
GlobeNewswire, Inc.
·
September 8, 2025
BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA (orelabrutinib) has been approved by the Health...
QuantaSing to Report Fourth Fiscal Quarter and Full Fiscal Year 2025 Financial Results on September 17, 2025
GlobeNewswire, Inc.
·
September 11, 2025
BEIJING, Sept. 11, 2025 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading lifestyle solution provider empowering adults to live better and longer, today announced that it plans to release its...
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
GlobeNewswire, Inc.
·
September 5, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED...
DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight
GlobeNewswire, Inc.
·
September 8, 2025
New York, USA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight The DPP1 inhibitor market is experiencing significant growth, driven by the recent BRINSUPRI approval for...